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Background: Complementary and alternative medicines (CAM) are used widely for treating atopic eczema (AE), commonly 
in conjunction with conventional medicines prescribed by mainstream healthcare professionals (HCPs). This cross-sectional 
survey evaluated the knowledge, general attitudes and practices regarding CAM among dermatologists, paediatricians, general 
practitioners (GPs) and pharmacists treating patients with AE in Durban, KwaZulu-Natal.
Methods: Questionnaires were sent via email or hand-delivered to HCPs nearby.
Results: Of the 330 respondents, 220 (67%) were males and 110 (33%) females. Most (40%) were > 50 years. GPs and pharmacists 
were significantly more embracing of CAM compared with dermatologists and paediatricians. The majority were not familiar 
with most CAMs for AE. More GPs (29%) and pharmacists (43%) recommend CAM compared with dermatologists (8%) and 
paediatricians (5%). GPs and pharmacists were also amenable to referring patients to CAM practitioners. The majority do not 
initiate discussions with their patients regarding CAM use nor enquire when taking a history. Many dermatologists (65%) and 
pharmacists (51%) reported that their patients ask about CAM. All dermatologists, 95% of paediatricians, 87% of GPs and 55% 
of pharmacists reported having no training in CAM but believed it should be included in their curriculum. Most are interested in 
learning about CAM and agreed that it would better prepare them in managing patients.
Conclusion: This study demonstrated poor CAM knowledge and communication between HCPs and patients but a strong interest 
amongst HCPs to learn more. There is an urgent need for continuing education programmes and inclusion in undergraduate 
curriculums, which will assist HCPs in influencing better patient outcomes.
Keywords: atopic dermatitis, atopic eczema, attitudes, complementary and alternative medicine, complementary medicine, 
healthcare professionals, knowledge, practices, views
Background
Atopic eczema (AE) is one of the most common skin diseases 
affecting patients who present to dermatological practices in 
South Africa (SA).1 Over the last decade, the lifetime prevalence 
of physician-diagnosed AE has almost doubled in SA.2 This rise 
continues despite accessible effective treatments.3 Due to AE’s 
chronic, relapsing nature and the unattainability of complete 
clinical cure, patients are continually exploring complementary 
and alternative medicines (CAM) in search of a cure.3 CAM’s 
popularity in the management of AE is well established.4
Non-compliance with therapy is a major contributor to AE’s 
persistence. Reported non-compliance rates are 30–60% with 
most regimes.5 Common reasons cited for non-compliance were 
apprehension of the danger of steroids, concern about side 
effects of other prescribed medication and a preference for 
‘natural’ therapy.5 This presents a dilemma for practitioners for 
many reasons: unproven effectiveness of many CAM, less funding 
for medication with proven reliability, difficulty in evaluating 
treatment and perpetuation of ‘natural’ therapists’ perspectives 
that steroids are dangerous, resulting in long-term suffering.5
Although evident from the literature that patients have 
embraced CAM,3 healthcare professionals (HCP) may not be as 
embracing. Their attitude and knowledge of CAMs will influence 
their proactiveness in enquiring about CAM and confidently 
discussing proven/unproven remedies with their patients, 
thereby influencing an overall positive clinical experience and 
disease course.
Several international studies have explored the knowledge, 
attitudes and practices amongst general practitioners (GPs), 
physicians, pharmacists, paediatricians, academic doctors and 
other healthcare workers towards CAM.6–11 These studies focused 
on general CAM use and none within the context of a specific 
disease. We found no published studies conducted in SA or 
elsewhere investigating HCPs’ knowledge, attitudes and norms 
of practice with regard to CAMs for AE. Given the extensive use 
among South African patients with AE,12 the views and rationales 
among South African HCPs treating patients with AE requires 
investigation.
Objectives
We conducted a cross-sectional survey among mainstream HCPs 
treating patients with AE in Durban, KwaZulu-Natal, with the aim 
of exploring their knowledge, awareness of use, 
recommendations, practices and attitudes to CAM use amongst 
their AE patients.
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Methods
The Ethics Committee of University of KwaZulu-Natal provided 
approval (BE219/14).
Study population
Practising dermatologists, paediatricians, GPs and pharmacists 
in Durban were selected randomly using professional societies’ 
databases and the telephone directory. HCPs had to be practising 
in a private practice where they treat AE patients; however, 
dermatologists and paediatricians were also considered if they 
consult in the public sector. Sample sizes were calculated based 
on population estimates of each group of HCPs represented in 
this study in Durban and surrounding areas (within 20 km).
Participants were recruited between October 2014 and February 
2015. A total of 330 HCPs responded to the survey: 25/34 
dermatologists (74% response rate); 41/61 paediatricians (67% 
response rate); 182/570 general practitioners (33% response 
rate); 82/158 retail pharmacists (52% response rate).
Data collection
Participants were sent an email with a link to the questionnaire. 
Questionnaires were also hand-delivered to HCPs practising 
nearby. Three reminders were sent electronically and via 
telephone calls.
The questionnaire covered the following sections:
•  practitioner and practice particulars;
•  general and demographic particulars of the HCP;
•  views on/attitudes to CAM for eczema;
•  knowledge of CAM for eczema;
•  professional practices with regard to CAM;
•  education regarding CAM for eczema.
Statistical analyses
Data was analysed using Stata 13.0® (StataCorp LP, College 
Station, TX, USA). Categorical data were summarised using 
frequencies and percentages. Association between type of HCP 
and attitudes, familiarity and practice using CAM variables were 
assessed using the Pearson chi-square test and Fisher’s exact test 
if any cell count contained fewer than five expected observations. 
We considered a p-value < 0.05 as being statistically significant.
Results
Demographics
The 330 HCPs respondents comprised 26 dermatologists, 40 
paediatricians, 182 GPs and 82 pharmacists. There were 220 
(67%) males and 110 (33%) females; 113 (34%) were Muslim 
practitioners, 104 (32%) Hindu, 99 (30%) Christian and 1 (0.3%) 
Buddhist. Two were atheist (0.6%), 1 agnostic (0.3%) and 10 did 
not respond (3%). The majority (132) were > 50 years (40%), 105 
(32%) were 31–40 years, 76 (23%) were 41–50 years and 17 (5%) 
were < 30 years. The majority were Indian practitioners (71%), 48 
(15%) White, 42 (13%) Black and 7 (2%) Coloured.
Our study demonstrated that there was no statistically significant 
demographic factor, e.g. age, gender, religion or ethnicity, that was a 
predictor of HCPs’ knowledge, attitudes and practices towards CAM.
Table 1: South African healthcare professionals’ views/attitudes towards 
CAM
Statement Agree Disagree Neutral
1. CAM provides a more holistic approach to health than conventional  
medicines (p = 0.002)
 Dermatologists (n = 26) 8% 46% 42%
 Paediatricians (n = 40) 13% 45% 43%
 General practitioners (n = 182) 32% 24% 45%
 Pharmacists (n = 82) 29% 22% 49%
2. Most CAM are safe and have very few side effects (p = 0.013)
 Dermatologists (n = 26) 15% 42% 38%
 Paediatricians (n = 40) 23% 45% 33%
 General practitioners (n = 182) 29% 34% 37%
 Pharmacists (n = 82) 37% 23% 40%
3. CAM can offer patients benefits that conventional medicines cannot  
(p = 0.001)
 Dermatologists (n = 26) 8% 46% 42%
 Paediatricians (n = 40) 18% 48% 35%
 General practitioners (n = 182) 36% 24% 41%
 Pharmacists (n = 82) 35% 23% 41%
4. The results of complementary therapies are due to the placebo effect  
(p < 0.001)
 Dermatologists (n = 26) 27% 12% 58%
 Paediatricians (n = 40) 45% 8% 48%
 General practitioners (n = 182) 16% 40% 43%
 Pharmacists (n = 82) 11% 46% 43%
5. Patients whose physicians are knowledgeable about CAM practices, in  
addition to conventional medicine, have better clinical outcomes (p < 0.001)
 Dermatologists (n = 26) 23% 12% 62%
 Paediatricians (n = 40) 20% 25% 55%
 General practitioners (n = 182) 52% 12% 37%
 Pharmacists (n = 82) 59% 7% 34%
6. Physicians should have knowledge about the most prominent CAM  
treatments (p = 0.013)
 Dermatologists (n = 26) 69% 8% 19%
 Paediatricians (n = 40) 73% 10% 18%
 General practitioners (n = 182) 81% 2% 17%
 Pharmacists (n = 82) 83% 5% 12%
7. While we need to be cautions in our claims, a number of CAM therapies 
hold promise for the treatment of symptoms, conditions and/or diseases  
(p < 0.001)
 Dermatologists (n = 26) 31% 19% 46%
 Paediatricians (n = 40) 25% 10% 65%
 General practitioners (n = 182) 55% 4% 41%
 Pharmacist (n = 82) 0% 0% 0%
8. CAM therapies should be subjected to more scientific testing before being 
accepted by conventional doctors (p = 0.886)
 Dermatologists (n = 26) 96% 0% 4%
 Paediatricians (n = 40) 88% 3% 10%
 General practitioners (n = 182) 87% 2% 11%
 Pharmacists (n = 82) 87% 1% 12%
(Continued)
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HCPs’ views/attitude towards CAM
Views/attitudes were assessed by the degree of agreement with 
general statements regarding CAM. Fewer specialists (8% 
dermatologists and 13% paediatricians) felt that CAM provides a 
more holistic healthcare approach compared with GPs (32%) and 
pharmacists (29%) (p = 0.002). Again, fewer specialists (8% 
dermatologists and 18% paediatricians) felt that CAM can offer 
benefits over conventional medicines compared with GPs (36%) 
and pharmacists (35%) (p = 0.001). Regarding the perception that 
the results from CAM are due to a placebo effect, more specialists 
(45% paediatricians and 27% dermatologists) than GPs (16%) and 
pharmacists (11%) were of this opinion (p < 0.001). More GPs 
(52%) and pharmacists (59%) felt that if physicians were more 
knowledgeable about CAM practices, their patients would have 
better clinical outcomes (p < 0.001). None of the dermatologists 
and only 3% of paediatricians felt that CAM produced a more 
complete clinical cure than conventional medicines. This was 
significantly less than the views of GPs (14%) and pharmacists 
(16%) (p = 0.037). More dermatologists (35%) and paediatricians 
(30%) felt that CAM interferes with standard medical care 
compared with GPs and pharmacists (both 15%) (p < 0.001).
These results are represented in Table 1.
HCPs’ familiarity regarding CAM
The percentage of HCPs that reported being very familiar with any 
of the CAMs frequently used for AE were low. Most were slightly 
familiar with probiotics and dietary supplements. However, it was 
evident that all HCPs were unfamiliar with the majority of the 
CAMs listed in Table 2, with higher levels of unfamiliarity regarding 
Chinese herbal medicines (CHM) and homeopathy. GPs and 
pharmacists were more familiar with oral and topical herbal 
products than dermatologists and paediatricians.
HCPs’ familiarity is shown in Table 2.
HCPs’ professional practices regarding CAM
The majority of HCPs never/rarely initiate discussions regarding 
CAM for AE (p = 0.006) and only sometimes have discussions 
with patients when a patient requests a CAM (no difference 
across HCP groups was noted) (p = 0.698). Although most 
reported not being confident in discussing CAM therapies with 
their patients, the majority reported that they always believe 
that HCPs treating patients for AE should regularly ask about 
CAM use. In general, most HCPs were unhappy to refer patients 
to CAM practitioners. More specialists (54% of dermatologists 
Table 2: South African healthcare professionals’ familiarity regarding CAM




1. Homeopathy (p < 0.001)
 Dermatologists (n = 26) 69% 15% 12%
 Paediatricians (n = 40) 83% 15% 3%
 General practitioners 
(n = 182) 60% 34% 7%
 Pharmacists (n = 82) 41% 48% 11%
2. Chinese herbal medicines (p < 0.001)
 Dermatologists (n = 26) 54% 35% 8%
 Paediatricians (n = 40) 93% 8% 0%
 General practitioners 
(n = 182) 87% 9% 4%
 Pharmacists (n = 82) 84% 12% 4%
3. Probiotics (p < 0.001)
 Dermatologists (n = 26) 27% 58% 12%
 Paediatricians (n = 40) 40% 45% 15%
 General practitioners 
(n = 182) 35% 45% 21%
 Pharmacists (n = 82) 22% 33% 45%
4. Dietary supplements (p = 0.002)
 Dermatologists (n = 26) 35% 50% 12%
 Paediatricians (n = 40) 28% 63% 10%
 General practitioners 
(n = 182) 23% 51% 26%
 Pharmacists (n = 82) 13% 54% 33%
5. Oral herbal products, e.g. evening primrose oil, borage oil (p < 0.001)
 Dermatologists (n = 26) 50% 23% 23%
 Paediatricians (n = 40) 68% 28% 5%
 General practitioners 
(n = 182) 38% 48% 13%
 Pharmacists (n = 82) 17% 57% 26%
6. Topical herbal creams, e.g. calendula, chamomile, St John’s Wort (p < 0.001)
 Dermatologists (n = 26) 46% 42% 8%
 Paediatricians (n = 40) 58% 40% 3%
 General practitioners 
(n = 182) 41% 46% 14%
 Pharmacists (n = 82) 17% 61% 22%
Statement Agree Disagree Neutral
9. CAM can produce longer lasting and more complete clinical results than 
conventional medicines (p = 0.003)
 Dermatologists (n = 26) 0% 58% 42%
 Paediatricians (n = 40) 3% 53% 45%
 General practitioners (n = 182) 17% 29% 54%
 Pharmacists (n = 82) 11% 34% 55%
10. I am annoyed when I find out my patients are using CAM without telling 
me (p = 0.034)
 Dermatologists (n = 26) 35% 31% 31%
 Paediatricians (n = 40) 28% 33% 40%
 General practitioners (n = 182) 14% 55% 31%
 Pharmacists (n = 82) 16% 50% 34%
11. CAM means quackery and makes fraudulent claims (p = 0.002)
 Dermatologists (n = 26) 12% 46% 42%
 Paediatricians (n = 40) 13% 20% 68%
 General practitioners (n = 182) 6% 58% 36%
 Pharmacists (n = 82) 10% 51% 39%
12. Interferes with standard medical care (p < 0.001)
 Dermatologists (n = 26) 35% 19% 46%
 Paediatricians (n = 40) 30% 13% 58%
 General practitioners (n = 182) 15% 48% 37%
 Pharmacists (n = 82) 15% 49% 37%
Table 1: (Continued)
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Patients requesting CAM
More than half of the dermatologists (65%) and pharmacists 
(51%) reported that their patients ask questions about or request 
CAMs for AE. Fewer paediatricians (33%) and GPs (36%) reported 
this (p = 0.005).
HCPs’ knowledge/education regarding CAM
All dermatologists and most paediatricians (95%) and GPs 
(85%) had no training in CAM compared with 55% of 
pharmacists (p < 0.001). A larger number of specialists did not 
access medical journals (p < 0.001), the internet (p = 0.005) or 
have discussions with other colleagues regarding CAM (p = 
0.037) compared with GPs and pharmacists. Comparatively, 
pharmacists were among the HCPs who sourced CAM 
information most often. The majority of paediatricians (85%), 
GPs (83%) and pharmacists (82%) reported that CAM is never 
discussed at meetings whereas more than half of the 
dermatologists reported CAM being discussed in congresses (p 
< 0.001). Table 4 reflects these results.
HCPs’ perspectives on CAM education
On assessing the HCPs’ perspectives on CAM education, the 
majority responded positively to universities including CAM as 
part of the curriculum (p = 0.001). Most agreed that learning 
about CAM would better prepare them for treating patients 
with AE (p = 0.004) and the majority were interested in learning 




The widespread use of CAM for AE among patients worldwide 
has been documented.13 Data have also revealed extensive use 
among South African AE patients.12 We thus explored the 
knowledge, attitudes and practices of South African HCPs in 
respect of CAM for AE.
The attitudes among HCPs in our study varied. Those with 
specialist training (dermatologists and paediatricians) 
were more sceptical, uncertain about the value and less 
receptive towards CAM compared with GPs and pharmacists 
who were significantly more positive and embracing of 
CAM.
and 45% of paediatricians) reported never being happy to refer 
patients to CAM practitioners compared with GPs (25%) and 
pharmacists (22%).
HCPs’ professional practice habits are shown in Table 3.
HCPs’ recommendation of CAM
Most South African HCPs do not recommend CAM for AE. However, 
in comparison, the majority of specialists (92% dermatologists 
and 95% paediatricians) do not recommend CAM compared with 
GPs (71%) and pharmacists (57%) (p < 0.001). This reflects a 
substantial number of GPs and pharmacists that do recommend 
CAM.  Figure 1 represents these results.
Table 3: South African healthcare professionals’ practices regarding CAM
Statement Always Never Often Rarely Sometimes
1. I initiate a discussion with patients regarding CAM for their eczema  
(p = 0.006)
 Dermatologists (n = 26) 0% 65% 4% 12% 19%
 Paediatricians (n = 40) 0% 55% 5% 28% 13%
 General practitioners 
(n = 182) 4% 29% 12% 31% 24%
 Pharmacists (n = 82) 7% 31% 9% 23% 29%
2. I have a discussion when a patient requests CAM for their eczema (p = 0.698)
 Dermatologists (n = 26) 4% 19% 23% 19% 34%
 Paediatricians (n = 40) 5% 15% 15% 30% 35%
 General practitioners 
(n = 182) 12% 12% 19% 22% 36%
 Pharmacists (n = 82) 13% 17% 21% 15% 34%
3. I ask about CAM use when taking a medication history for a new patient  
(p = 0.110)
 Dermatologists (n = 26) 0% 27% 31% 23% 19%
 Paediatricians (n = 40) 18% 23% 13% 18% 30%
 General practitioners 
(n = 182) 18% 20% 26% 16% 20%
 Pharmacists (n = 82) 15% 10% 22% 24% 29%
4. I am confident discussing CAM therapies with patients (p = 0.036)
 Dermatologists (n = 26) 4% 42% 12% 31% 12%
 Paediatricians (n = 40) 5% 35% 8% 35% 18%
 General practitioners 
(n = 182) 6% 25% 13% 33% 23%
 Pharmacists (n = 82) 10% 12% 10% 30% 38%
5. I believe that health practitioners treating patients for their eczema should 
regularly ask patients if they are using CAM therapies (p = 0.138)
 Dermatologists (n = 26) 54% 0% 23% 0% 23%
 Paediatricians (n = 40) 30% 3% 35% 8% 25%
 General practitioners 
(n = 182) 44% 4% 26% 7% 19%
 Pharmacists (n = 82) 57% 1% 29% 2% 10%
6. I am happy to refer patients to CAM practitioners e.g. Homeopaths, herbalists 
etc. for complementary treatment for their eczema (p = 0.002)
 Dermatologists (n = 26) 0% 54% 0% 35% 12%
 Paediatricians (n = 40) 3% 45% 5% 25% 23%
 General practitioners 
(n = 182) 8% 25% 9% 19% 38%

























Figure 1: Percentage of healthcare professionals that recommend CAM 
for eczema (p < 0.001).
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This positive attitude was seen in several other studies. A Texas-
based study reported that a large number of GPs were positive 
about incorporating CAM into general practice (75%), referring 
patients to CAM practitioners (> 60%) and offering proven CAM 
therapies to patients (70%).10 Saudi Arabian primary healthcare 
physicians also showed a positive attitude and 76% believed that 
CAM would lead to a better patient outcome.14 GPs in a Qatar 
survey reflected support of CAM with 83% agreeing that it is a 
useful supplement to conventional medicine and included ideas 
and methods beneficial to the primary care physician.6 The 
overall attitudes of Australian GPs and pharmacists towards CAM 
are positive.15 In a South African-based study among pharmacists, 
almost half (47%) believed in the benefits of both conventional 
and herbal medicines and 64% perceived herbs to be 
therapeutically effective drugs.16 Our survey shows a similar 
positive attitude among GPs and pharmacists.
Conversely, certain studies have demonstrated scepticism and 
uncertainty about CAM’s value. The majority of academic 
doctors with dual academic and clinical roles in a Bristol, UK 
study expressed doubt due to the lack of scientific evidence.9 
This scepticism is seen amongst South African specialists 
(dermatologists and paediatricians) in our survey with many 
also having dual academic and clinical roles. The Texas-based 
study among GPs reported that in comparison with another 
study using the same instrument, a more positive attitude was 
seen among primary care practitioners compared with non-
primary care peers (sub-speciality physicians) at the Mayo 
Clinic.10 GPs are generally based within the community and are 
exposed to a variety of diseases for which patients are using 
CAM. This type of family medical practice seems a more open 
forum for patients and doctors to discuss CAM choices, thus 
realising a more open approach from GPs. A study among 
paediatricians in the Netherlands, however, found a positive 
attitude towards CAM, mostly towards probiotics and dietary 
supplements whose action can be rationalised with those of 
conventional medicines.
Familiarity
The scepticism among HCPs can be attributed to their lack of 
knowledge. On assessing knowledge/familiarity, it was evident 
that the majority were unfamiliar with most CAMs for AE. GPs and 
pharmacists were more familiar with herbal products (oral and 
topical) compared with specialists. Higher levels of unfamiliarity 
were seen with CHM and homeopathy, possibly because the 
theory behind their action differs vastly from conventional 
medicine, as well as the limited exposure to CHM practitioners in 
Durban. Another Durban-based study amongst healthcare 
workers in HIV/AIDS clinics reflected poor CAM knowledge 
including homeopathy and CHM.11 Likewise, 81% of Turkish 
dermatologists reported very little/no knowledge of CAM and 
more than half of paediatricians surveyed in the Netherlands also 
had little knowledge of CAM therapies.17 Studies among GPs in 
Qatar and Saudi Arabia reported similar poor CAM knowledge 
(39% and  >  63% respectively).6,14 However, several Australian 
surveys indicate that GPs are familiar with a wide range of CAM 
therapies.15 Australian pharmacists reported that while a lack of 
knowledge about safety was a definite barrier to their 
recommendation, they still often recommended CAM alongside 
conventional medicines as part of the pharmacy protocol.7
Recommendations and referrals
Although most HCPs do not recommend CAM to their patients, 
more GPs (29%) and pharmacists (43%) do so compared with 









































































Figure 2: South African healthcare professionals’ perspectives on CAM 
education.
Table 4: South African healthcare professionals’ education regarding CAM




1. Did you have any training on CAM? (p < 0.001)
 Dermatologists (n = 26) 100% 0% 0%
 Paediatricians (n = 40) 95% 3% 3%
 General practitioners  
(n = 182) 87% 8% 4%
 Pharmacists (n = 82) 55% 37% 9%
2. Do you access any medical journals to source information on CAMs for 
eczema? (p < 0.001)
 Dermatologists (n = 26) 77% 15% 8%
 Paediatricians (n = 40) 83% 10% 8%
 General practitioners  
(n = 182) 68% 26% 6%
 Pharmacists (n = 82) 44% 50% 6%
3. Do you access any information on the internet with regard to CAMs for 
eczema? (p = 0.006)
 Dermatologists (n = 26) 62% 27% 12%
 Paediatricians (n = 40) 68% 25% 8%
 General practitioners  
(n = 182) 59% 31% 9%
 Pharmacists (n = 82) 35% 45% 20%
4. Do you have discussions with other colleagues about CAM use for eczema? 
(p = 0.034)
 Dermatologists (n = 26) 62% 38% 0%
 Paediatricians (n = 40) 78% 23% 0%
 General practitioners  
(n = 182) 64% 30% 5%
 Pharmacists (n = 82) 48% 43% 9%
5. Is CAM for eczema discussed in congresses you have attended? (p < 0.001)
 Dermatologists (n = 26) 35% 58% 8%
 Paediatricians (n = 40) 85% 15% 0%
 General practitioners  
(n = 182) 83% 15% 2%
 Pharmacists (n = 82) 82% 15% 4%
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Education
Our survey revealed that most South African HCPs acknowledge 
their lack of knowledge on CAM and want to be better informed. 
This lack of knowledge is due to lack of training in CAM in both 
the undergraduate and continuing education programmes. All 
dermatologists, 95% of paediatricians and 87% of GPs reported 
having no training in CAM. Pharmacists, on the other hand, have 
had a little more CAM training (45%). The majority of respondents 
believed that universities should include CAM as part of their 
curriculum. A similar number also agreed that learning about 
CAM would better prepare them for managing patients and are 
interested in learning more. These views correlate with other 
studies which have recommended that CAM be included in 
undergraduate medical and pharmacy curricula.7,16 Among Saudi 
Arabian primary healthcare physicians, 85% agreed that they 
should have knowledge of CAM.14 In Qatar, almost all GPs (98%) 
were interested to learn more about CAM and most 
dermatologists in a study in Turkey also claimed that they would 
like to be better informed about CAM.17 In a survey amongst 
paediatricians in Michigan, USA, 54% were keen on continuing 
medical education courses for CAM.18 Academic doctors in 
Bristol, UK acknowledged that better doctor–patient 
communication and patient disclosure is required; however, 
their views on educating themselves on CAM were varied.9 Our 
survey was comparable to most as the majority of HCPs (> 72% 
specialists, > 90% GPs and pharmacists) said that they wanted to 
learn more about CAM for AE.
Limitations
Although this study has been compared with those in other 
countries, our study was reflective of CAM practices specifically 
for AE whereas those of other countries were on general use of 
CAM. It is presumed that the attitudes, knowledge and practices 
of CAM for AE would be similar to CAM use in other contexts. The 
responses in the study may not represent the views of all South 
African HCPs as our study sample were majority Indian HCPs 
within the Durban metropolitan area.
Conclusion
It is clear that CAM is an established therapy for a large part of 
the population and, considering that CAM and conventional 
medicine are often used together, there is a potential for 
confusion in attribution of therapeutic benefits, adverse effects 
and drug interactions. Their concomitant use also creates a 
potential for non-compliance with prescribed therapy affecting 
overall clinical outcome. It is imperative that HCPs initiate 
discussions as well as realise and accept a responsibility in 
understanding their evidence-based role. HCPs need to become 
more conversant with common CAM therapies in order to 
influence better patient management and possibly better 
outcomes. Our study demonstrated poor CAM knowledge and 
communication between HCP and patient but a strong interest 
amongst HCPs to learn more.
Funding – This work was supported by The National Research 
Foundaton Thuthuka Funding Instrument [TTK14061769473].
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with the specialists (Table 3). Both practices are reflective of their 
general attitudes towards CAM. The concern is that those 
recommending CAM are doing so without adequate knowledge/
training. This lack of knowledge/training was reported among 
the majority of respondents in our study but did vary depending 
on CAM type. Recommendations despite knowledge were seen 
among Turkish dermatologists where 80% reported little/no 
knowledge, yet more than half have at some stage recommended 
topical herbal therapies and a significant proportion other herbal 
therapies.17 With regard to referrals, 50% of paediatricians in a 
Michigan, USA study said that they would refer patients to CAM 
practitioners whereas only 27% of paediatricians in the 
Netherlands occasionally refer patients.18 In a survey among 
Durban pharmacists, only 8% considered themselves sufficiently 
equipped to advise patients, yet 45% indicated that they did 
counsel patients on herbal medicines and these were 
recommended by 36% of respondents. In a Texas-based study, 
almost half (42%) of the primary HCPs did refer patients to CAM 
practitioners and 64% would like to.10 Referral rates were low 
among Qatar GPs where 39% stated that they had poor CAM 
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most were familiar with various CAM therapies.15
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(65%) and pharmacists (51%). It appears that patients frequently 
ask for CAM for skin diseases. On assessing HCPs’ practices when 
treating patients, our study indicated that the majority of South 
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Despite these practices, most believed that HCPs treating 
patients for AE should regularly ask patients if they are using 
CAM and most agreed that it is necessary for practitioners to 
have knowledge of the most prominent CAM treatments. As 
pharmacies are the major stockists of CAM products, patients 
expect pharmacists to have sufficient knowledge to advise 
them. This is an important aspect of a pharmacist’s service. This 
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also ask about its use when taking a history.20
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